Are you passionate about the #medicaltechnology sector? Then this is your ideal opportunity! Quibim is experiencing rapid growth, and we are looking for qualified individuals to join our exceptional team. We have several open positions and welcome candidates with diverse skills and experience. By joining our team, you will play a crucial role in our mission to revolutionize the healthcare industry using cutting-edge #AI technology. Together, we will transform #patientcare. Join the #Quibimteam! http://bit.ly/3m285Zf
🔍Cutting-edge imaging #technology, like magnetic resonance imaging (#MRI), is revolutionizing the detection of #prostatecancer. This non-invasive technology can identify early signs of #cancer with significantly great precision. Moreover, the integration of #machinelearning can enhance detection accuracy even further, offering a less invasive and more accurate alternative to traditional biopsies. This advancement can lead to an improved patient experience and potentially save lives. Check out our website to find more about it https://bit.ly/3oNjnl2 #healthtech
How can #AI and computed tomography aid in identifying NSCLC patients who will respond best to #immunotherapy? That was the challenge faced by a leading bio-pharmaceutical company in collaboration with Quibim. Through analysis of a large CT scan database, Quibim designed and validated an artificial intelligence algorithm based on #radiomics and deep learning that can predict treatment response with 80% accuracy. This solution could help improve patient selection for future clinical trials, optimize drug development programs and is implemented as a continuous process that can communicate directly with the hospital's picture archiving and communication system (PACS) 🏥💻 Discover more about this exciting collaboration and its benefits for the bio-pharmaceutical industry and #precisionmedicine 🤝
At Quibim, we believe in supporting our employees' growth and professional development in every aspect of their lives. Being an international team, we understand the immense value of language skills in today's interconnected world. By offering language classes to our employees, we create a supportive and inclusive work environment that values diversity, facilitates effective communication, and enables individuals to thrive in a globalized world. At Quibim, we believe that offering this is not just an added benefit but an integral part of our business model. In addition, by attending these lessons, Quibimers get to know each other better. Join our team and embark on a journey of personal and professional growth! #beaquibimer
We are thrilled to be part of the #FLUTE kick-off meeting that is taking place today and tomorrow in Lille, France. The FLUTE platform represents a revolutionary federated infrastructure that will transform how we handle health #data. Our mission is to revolutionize data-driven healthcare by developing advanced privacy-preserving, cross-border data collaboration methods. This project aims to sharpen predictions of aggressive #prostatecancer while reducing unnecessary biopsies. With FLUTE, we can deploy large-scale #machinelearning models across multiple data centers without compromising sensitive patient data. Instead of transferring data, our innovative approach involves training a general AI healthcare model locally on each dataset and transmitting it between data centers. This process ensures privacy protection while still extracting valuable insights. We are excited to contribute to advancing data-driven healthcare and shape the future of secure and collaborative data analysis. Stay tuned for updates on our progress in this ambitious project.
At Quibim, we believe in supporting our employees' growth and professional development in every aspect of their lives. Being an international team, we understand the immense value of language skills in today's interconnected world. By offering language classes to our employees, we create a supportive and inclusive work environment that values diversity, facilitates effective communication, and enables individuals to thrive in a globalized world. At Quibim, we believe that offering this is not just an added benefit but an integral part of our business model. In addition, by attending these lessons, Quibimers get to know each other better. Join our team and embark on a journey of personal and professional growth! #beaquibimer
Join The CHAIMELEON Project Open Challenges: A unique opportunity for scientists globally to advance cancer research using #AI. This initiative is aimed at developing impactful solutions for cancer diagnosis and treatment. The challenge is structured to train AI models to answer clinical queries about five types of #cancer - prostate, lung, breast, colon, and rectal. Prizes totaling up to €100,000 will be distributed among the winners. Are you interested in contributing to the development of AI-powered tools for cancer? Click the link to register now https://bit.ly/3pFyAFr
Our team is thrilled to be at the International Cancer Imaging Society Congress at the Champalimaud Centre for the Unknown in Lisbon. We're looking forward to engaging with leading experts on this year's theme, 'Enhancing Healthcare Through #AI,' and discussing the latest developments in the field.
Exciting times at the ProCAncer-I project consortium meeting in Lisbon that took place this week! It's a pleasure to be working side by side with our partners as we make strides towards our common aim. This project is a beacon of innovation, addressing the clinical unmet needs in #prostatecancer treatment. We're focusing on key areas including diagnosis, detection of metastasis, and predicting treatment responses, all made possible through advanced #machinelearning models. During these two days, we had the opportunity to showcase our cutting-edge work, discussing our progress on deep learning methodologies for semi-automated segmentation. We also debated about the redefining of exploitation and sustainability of the project within the context of European Federation for Cancer Images (EUCAIM). Together, we are taking significant steps to revolutionize prostate cancer #patientcare. Stay tuned for more updates on our journey!
Our CEO Ángel Alberich-Bayarri attended the closing session of the #IMAS project, a pioneering project to build an innovative full-body PET device which aim is to reduce the duration of examinations, increase the number of patients examined per day and improve disease monitoring. The participation of Quibim in the IMAS project has contributed to creating a #medicaldevice that incorporates an automated system to detect and characterize the organs and the lesions using #AI, this certainly improves diagnostic certainty and assesses efficiently the treatment response of different pathologies.
